Prostate Cancer Market by Specialized Product Types – Hormone Therapy, Targeted Therapies and Therapeutic Vaccines 2027 Insight; MarketResearchFuture.com

The International Prostate Cancer market report titled “Prostate Cancer Market Research Report - Global Forecast To 2027” report provide overview of key players and their strategic profiling in the market.

Pune, India - April 10, 2018 /MarketersMedia/ —

Global Prostate Cancer Market – Overview:

Generally, prostate cancer is a disease of the prostate gland. These glands are responsible for the production and secretion of prostate fluid as a component of semen in addition to that it also acts as a regulator of urine control in men.

As per a survey conducted by the American Cancer Society, about 1 in 7 men are estimated to be diagnosed with prostate cancer during their lifetime. Moreover, according to a UK based government institute namely Cancer Research Organization estimated that nearly 46,690 new cases of prostate cancer were diagnosed in 2014 with a death toll of 11,287 patients.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1580 .

Furthermore, there are various initiatives undertaken by key players to collaborate with government organization to spread awareness regarding the clinical symptoms of prostate cancer. Moreover, the promotion of diagnostic & screening tests for early detection such as Digital Rectal Exam (DRE), and Prostate-Specific Antigen (PSA). In addition, major players including Dendreon Corporation, Sanofi, AstraZeneca Plc, Johnson & Johnson Inc., and Astellas Pharms, Inc., are aiming to develop safe and effective therapeutic products to treat tumor.

Besides, blockbuster drugs such as Zytiga, Taxotere, Xtandi, Eligard, Xofigo, and Provenge, holding a robust position in the global prostate cancer market. Johnson & Johnson’s brand Zytiga is considered as a gold standard for the treatment of prostate cancer. Rise in the funding in both private and public sector for the drug development, technological advancements in finding new techniques to fight prostate cancer,  lifestyle changes, are few factors driving the growth of the market. Side effects of surgery such as urinary impotence & incontinence and surgical risks such as blood clots, stroke, and heart attack are certain constraints encountered by the global prostate cancer market.

Industry Updates:

March, 2018 Astellas pharma received FDA approval for Xtandi tablets, a treatment for castration-resistant prostate cancer, in Japan

Jan, 2015 Janssen Pharmaceutical Companies r received FDA approval for Zytiga (abiraterone acetate) for the treatment of prostate cancer

Global Prostate Cancer Market - Regional Analysis

The Global Prostate Cancer Market is expected to grow with a CAGR of approximately 10.5% during the forecast period from 2017-2027.

The global prostate cancer market is segmented into five major regions including Americas, Europe, Asia Pacific, and Middle East and Africa region.

Americas dominated the global prostate cancer market in terms of revenue share owing to the increasing R&D in the region and presence of big outsourcing firms. In the U.S., it is the most common cancer in men, but it is also treatable if found in the early stages. Prostate Cancer Foundation of Canada supports research, cure, and prevention of prostate cancer via online portal. According to the American Cancer Society in 2017 expected that about 161,360 new cases of prostate cancer will be diagnoses, and that around 26,730 fatalities will occur because of it.

The European market is the second largest market for prostate cancer plays an important role to minimize the cost of clinical trials. Furthermore, Asia Pacific region has emerged as the fastest growing market for prostate cancer.

The Middle-East and Africa prostate cancer market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future.

Get Discount @ https://www.marketresearchfuture.com/check-discount/1580 .

Major TOC for Global Prostate cancer Market Research Report- Forecast To 2027:

1 INTRODUCTION

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure

2 RESEARCH METHODOLOGY

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 MARKET DYNAMICS

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4 MARKET FACTOR ANALYSIS

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

TOC Continued….!

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1580 .

The report provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Prostate cancer market.  The report analyzes the prostate cancer market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: [email protected]
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/prostate-cancer-market-by-specialized-product-types-hormone-therapy-targeted-therapies-and-therapeutic-vaccines-2027-insight-marketresearchfuture-com/328289

For more information, please visit https://www.marketresearchfuture.com/reports/prostate-cancer-market-1580

Source: MarketersMedia

Release ID: 328289